Citigroup’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1B Buy
1,091,983
+432,352
+66% +$438M 0.43% 39
2025
Q4
$709M Buy
659,631
+1,298
+0.2% +$1.24M 0.31% 53
2025
Q3
$502M Sell
658,333
-404,784
-38% -$301M 0.22% 70
2025
Q2
$829M Sell
1,063,117
-80,573
-7% -$62.6M 0.41% 38
2025
Q1
$945M Buy
1,143,690
+444,836
+64% +$370M 0.48% 32
2024
Q4
$540M Sell
698,854
-53,572
-7% -$44.4M 0.32% 47
2024
Q3
$667M Sell
752,426
-22,208
-3% -$20M 0.39% 45
2024
Q2
$701M Buy
774,634
+158,051
+26% +$126M 0.45% 36
2024
Q1
$480M Buy
616,583
+33,482
+6% +$23.8M 0.32% 52
2023
Q4
$340M Sell
583,101
-76,807
-12% -$44.8M 0.24% 70
2023
Q3
$354M Sell
659,908
-31,213
-5% -$16.1M 0.27% 59
2023
Q2
$324M Sell
691,121
-64,176
-8% -$26.9M 0.21% 68
2023
Q1
$259M Sell
755,297
-78,531
-9% -$26.5M 0.18% 82
2022
Q4
$305M Sell
833,828
-172,203
-17% -$61.1M 0.24% 70
2022
Q3
$325M Buy
1,006,031
+274,428
+38% +$86.9M 0.23% 68
2022
Q2
$237M Sell
731,603
-58,818
-7% -$17.7M 0.18% 96
2022
Q1
$226M Buy
790,421
+27,710
+4% +$7.13M 0.14% 125
2021
Q4
$211M Sell
762,711
-42,941
-5% -$10.9M 0.11% 160
2021
Q3
$186M Sell
805,652
-63,287
-7% -$15.6M 0.11% 161
2021
Q2
$199M Sell
868,939
-16,058
-2% -$3.23M 0.12% 152
2021
Q1
$165M Buy
884,997
+212,304
+32% +$41.5M 0.11% 173
2020
Q4
$114M Sell
672,693
-39,246
-6% -$5.86M 0.07% 263
2020
Q3
$105M Sell
711,939
-35,184
-5% -$5.45M 0.07% 231
2020
Q2
$123M Sell
747,123
-86,746
-10% -$13.3M 0.1% 178
2020
Q1
$116M Buy
833,869
+42,915
+5% +$5.9M 0.1% 157
2019
Q4
$104M Buy
790,954
+161,843
+26% +$18.8M 0.08% 243
2019
Q3
$70.4M Sell
629,111
-1,198,333
-66% -$133M 0.06% 330
2019
Q2
$202M Buy
1,827,444
+1,076,512
+143% +$127M 0.16% 104
2019
Q1
$97.4M Buy
750,932
+89,696
+14% +$10.9M 0.09% 193
2018
Q4
$76.5M Buy
661,236
+124,691
+23% +$13.9M 0.08% 248
2018
Q3
$57.6M Buy
536,545
+43,423
+9% +$4.34M 0.05% 335
2018
Q2
$42.1M Sell
493,122
-620,806
-56% -$51M 0.04% 428
2018
Q1
$86.2M Buy
1,113,928
+53,944
+5% +$4.34M 0.07% 235
2017
Q4
$89.5M Buy
1,059,984
+137,275
+15% +$11.7M 0.07% 247
2017
Q3
$78.9M Buy
922,709
+27,290
+3% +$2.24M 0.06% 255
2017
Q2
$73.7M Buy
895,419
+204,117
+30% +$16.7M 0.07% 234
2017
Q1
$58.1M Buy
691,302
+107,018
+18% +$8.57M 0.05% 309
2016
Q4
$43M Sell
584,284
-372,305
-39% -$27.7M 0.04% 427
2016
Q3
$76.8M Sell
956,589
-106,867
-10% -$8.55M 0.07% 240
2016
Q2
$83.7M Buy
1,063,456
+149,266
+16% +$11.2M 0.09% 223
2016
Q1
$65.8M Sell
914,190
-514,444
-36% -$38.9M 0.07% 247
2015
Q4
$120M Buy
1,428,634
+302,778
+27% +$25.1M 0.12% 141
2015
Q3
$94.2M Sell
1,125,856
-36,610
-3% -$3.09M 0.09% 180
2015
Q2
$97.1M Sell
1,162,466
-139,397
-11% -$10.6M 0.09% 213
2015
Q1
$94.6M Sell
1,301,863
-462,141
-26% -$32.9M 0.09% 196
2014
Q4
$122M Sell
1,764,004
-401,385
-19% -$27.1M 0.11% 177
2014
Q3
$140M Sell
2,165,389
-870,097
-29% -$55.1M 0.12% 131
2014
Q2
$189M Sell
3,035,486
-127,461
-4% -$7.6M 0.18% 77
2014
Q1
$186M Buy
3,162,947
+1,349,379
+74% +$75.3M 0.19% 77
2013
Q4
$92.5M Buy
1,813,568
+43,330
+2% +$2.17M 0.08% 216
2013
Q3
$89.1M Sell
1,770,238
-116,292
-6% -$6.09M 0.08% 217
2013
Q2
$92.7M Buy
+1,886,530
New +$103M 0.09% 166

Other funds holding LLY

Citigroup's LLY Position: Q1 2026 in Review

Citigroup increased its Eli Lilly (LLY) stake by 66% in Q1 2026, buying an estimated $438M and bringing the position to 1,091,983 shares worth $1B. The position accounts for 0.43% of the portfolio, ranked #39.

Citigroup first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Citigroup held 1,091,983 shares of Eli Lilly worth $1B as of Q1 2026.
  • Citigroup bought 432,352 Eli Lilly shares in Q1 2026, an estimated $438M.
  • Eli Lilly made up 0.43% of Citigroup's portfolio in Q1 2026, its #39 holding.
  • Citigroup first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.